1. Home
  2. Browse
  3. Cardiology
  4. Dyslipidemia

Dyslipidemia

166 - 177 of 177 Results
Sort Results:
Guideline: Working Group on Hypercholesterolemia Recommendations for the Management of Dyslipidemia and the Prevention of Cardiovascular Disease: 2003 Update October 2006
Guideline: Third Report of the NCEP Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults and 2004 Update on Implications of Recent Clinical Trials for the NCEP ATP III Guidelines October 2006
Guideline: Canadian Cardiovascular Society Recommendations for the Diagnosis and Treatment of Dyslipidemia and Prevention of Cardiovascular Disease October 2006
Article: whether patients can use other niacin products in place of Niaspan December 2005
Commentary: Niacin Use: An Update December 2005
Other: New Drug: Lovaza (formerly Omacor) (Omega-3 Acid Ethyl Esters) October 2005
Article: Omacor will be the first PRESCRIPTION omega-3 fatty acid product October 2005
Commentary: An Update on Potential New Uses for Statins July 2004
Guideline: ADA Position Statement on Dyslipidemia Management in Adults with Diabetes (2004) June 2004
Guideline: American College of Physicians Clinical Practice Guideline on Lipid Control in the Management of Type 2 Diabetes Mellitus (2004) June 2004
Commentary: Lipid Control in Diabetes: Review of Clinical Practice Guidelines June 2004
Commentary: Rosuvastatin (Crestor) August 2003